Why Takeda "just said no"























































Re: Why Takeda "just said no" ? Takeda targets GI ?? Dec 2014

Takeda targets gastrointestinal disease with its latest R&D deal
December 11, 2014 | By Damian Garde


Takeda, in the process of trimming down its R&D efforts, has inked a collaborative research deal with Australia's Monash University to discover and develop new treatments for gastrointestinal diseases.

Under the agreement, Takeda will fund a three-year research program in which investigators from the school's Institute of Pharmaceutical Sciences will work alongside its own scientists to break down the underlying causes of disorders like irritable bowel syndrome, severe constipation and chronic diarrhea. Leaning on the Melbourne university's expertise in drug discovery and nanomedicine, Takeda hopes to spotlight new therapeutic targets for unmet medical needs, the company said.